Cabaletta Bio Q1 Earnings: More Positive Data Suggests CAR-T Can Work In Autoimmune
Source: SeekingAlpha
2026-05-14 10:46:41 ET
Investment Overview - Preview To Today's Earnings News
I have issued Cabaletta Bio, Inc. ( CABA ) stock with Buy ratings in two previous notes for Seeking Alpha, the first in September 2023 , with stock trading ~$19 per share, and the next in June 2024 , at $7.5 per share....
Read the full article on Seeking Alpha
For further details see:
Cabaletta Bio Q1 Earnings: More Positive Data Suggests CAR-T Can Work In Autoimmune
Cabaletta Bio Inc.
NASDAQ: CABA
CABA Trading
-4.26% G/L:
$3.26 Last:
2,211,724 Volume:
$3.48 Open:
CABA Latest News
June 03, 2026 07:00:00 am
Cabaletta Bio Announces New Rese-cel Data and Development Updates Across Autoimmune Portfolio, Including Encouraging Early PC-Free Lupus Findings, at EULAR 2026 Congress
May 14, 2026 07:05:00 am
Cabaletta Bio Reports First Quarter 2026 Financial Results and Provides Business Update
CABA Stock Data
$250,770,856
85,435,369
1.33%
21
N/A
Biotechnology & Life Sciences
Healthcare
US
Philadelphia
